tiprankstipranks
Trending News
More News >
iX Biopharma Ltd. (SG:42C)
SGX:42C
Singapore Market

iX Biopharma Ltd. (42C) Income Statement

Compare
10 Followers

iX Biopharma Ltd. Income Statement

Last quarter (Q4 2024), iX Biopharma Ltd.'s total revenue was S$4.05M, an increase of 139.53% from the same quarter last year. In Q4, iX Biopharma Ltd.'s net income was S$-3.89M. See iX Biopharma Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
S$ 7.77MS$ 5.96MS$ 5.91MS$ 14.39MS$ 1.75M
Gross Profit
S$ 2.04MS$ 1.05MS$ 2.32MS$ 12.29MS$ -382.00K
Operating Expenses
S$ 8.32MS$ 8.44MS$ 10.73MS$ 11.05MS$ 11.05M
Depreciation and Amortization
S$ 854.00KS$ 868.00KS$ 929.00KS$ 1.06MS$ 642.00K
EBITDA
S$ -8.96MS$ -8.68MS$ -8.51MS$ -2.84MS$ -10.79M
Operating Income
S$ -6.29MS$ -7.39MS$ -8.41MS$ 1.24MS$ -11.43M
Other Income/Expenses
S$ -3.85MS$ -2.60MS$ -1.29MS$ -5.34MS$ 3.20M
Pretax Income
S$ -10.14MS$ -9.98MS$ -9.71MS$ -4.10MS$ -8.23M
Net Income
S$ -10.14MS$ -10.79MS$ -9.62MS$ -4.60MS$ -8.23M
Per Share Metrics
Basic EPS
S$ -0.01S$ -0.01S$ -0.01S$ -0.01S$ -0.01
Diluted EPS
S$ -0.01S$ -0.01S$ -0.01S$ -0.01S$ -0.01
Weighted Average Shares Outstanding
874.22M 767.36M 764.85M 754.63M 691.93M
Weighted Average Shares Outstanding (Diluted)
876.68M 767.36M 764.85M 754.63M 693.41M
Currency in SGD

iX Biopharma Ltd. Earnings and Revenue History